Skip to content
Israeli Founders

biotech, ai

Scala Biodesign

Computational protein-engineering software for drug developers, from Weizmann research

Total raised
$16M
Funding rounds
1
Headquarters
Rehovot

Scala Biodesign is an Israeli biotech and ai company1, headquartered in Rehovot1.

It has raised $16M across 1 funding round1; the most recent was a Series A round of $16M1, announced Mar 31, 20261.

Funding history

1 round

Funding rounds raised by Scala Biodesign, newest first
RoundAnnouncedAmountLead investors
Series AMar 31, 2026$16MGrove Ventures

Investors

Which Israeli startups are similar to Scala Biodesign?

Which startups share investors with Scala Biodesign?

Sources

  1. 1CTech, Mar 31, 2026. “Scala Biodesign raises $16 million Series A to accelerate AI-driven drug development”

How much funding has Scala Biodesign raised?

Scala Biodesign has raised $16M across 1 funding round.

What was Scala Biodesign’s latest funding round?

Scala Biodesign’s most recent round was a Series A round of $16M, announced Mar 31, 2026.

Who has invested in Scala Biodesign?

Investors in Scala Biodesign include Grove Ventures, TLV Partners, Deep Insight and Israel Innovation Authority.

Where is Scala Biodesign based?

Scala Biodesign is based in Rehovot.